Frequency Electronics Holds Annual Meeting, Elects Directors
Frequency Electronics Inc. held its Annual Meeting, electing directors and approving key measures with a 77.58% shareholder turnout.
bioAffinity Technologies Secures Patent for Lung Cancer Test
bioAffinity Technologies announces a Notice of Allowance for its CyPath® Lung test patent, advancing its lung cancer detection capabilities.
Picard Medical amends bylaws to lower quorum requirements
Picard Medical, Inc. has amended its bylaws to reduce the quorum for stockholder meetings, enhancing decision-making efficiency.
Vontier Corp's Chief Transformation Officer Resigns
Kathryn Rowen resigns as Vontier's Chief Transformation Officer, effective October 16, 2026, impacting the company's strategic direction in the industry.
Nova Minerals advances antimony processing plant construction
Nova Minerals Corp progresses to antimony processing plant construction, enhancing production capabilities and impacting the Gold and Silver Ores industry.
Perspective Therapeutics Receives FDA Fast Track Designation
Perspective Therapeutics, Inc. gains FDA Fast Track Designation for PSV359, enhancing its development prospects in treating specific tumors.
Northann Corp. Announces Executive Leadership Changes
Northann Corp. reveals new executive appointments, including a CEO change, signaling a strategic shift in the plastics products industry.
Toppoint Holdings Addresses Unusual Trading Activity
Toppoint Holdings clarifies unusual trading activity in its stock, confirming no undisclosed developments. Industry implications for trucking and courier services.
Corteva announces leadership changes in 8-K filing
Corteva, Inc. reveals leadership changes, including executive departures and new appointments, impacting the agricultural production industry.
Armstrong World Industries Announces New CEO Appointment
Armstrong World Industries has appointed a new CEO, signaling a strategic shift in leadership aimed at enhancing its position in the plastics products industry.
Copper Property CTL Pass Through Trust Declares Cash Distribution
Copper Property CTL Pass Through Trust announces a cash distribution of $0.076725 per trust certificate to be paid on October 13, 2026.
reAlpha Tech Corp. Shares Investor Presentation for Engagement
reAlpha Tech Corp. has posted an investor presentation aimed at enhancing engagement with investors and analysts, signaling a proactive communication strategy.
BioCardia to Present CardiAMP HF II Trial at Heart Failure Meeting
BioCardia, Inc. announces presentation of CardiAMP HF II Trial design at Heart Failure Society of America Annual Scientific Meeting, showcasing advancements in cell therapies.
EastGroup Properties Expands Board with Two New Directors
EastGroup Properties Inc. appoints two new independent directors, enhancing governance and oversight in the competitive real estate investment trust industry.
Beeline Holdings announces recent developments in press release
Beeline Holdings, Inc. issues a press release detailing recent developments, emphasizing transparency in the mortgage banking sector.
Mexico Fund Inc. Reports September 2026 Monthly Summary
Mexico Fund Inc. shares its September 2026 Monthly Summary Report, highlighting investment performance and distribution plans, reflecting trends in the investment industry.
Bioforce Nanosciences secures Texas oil and gas lease
Bioforce Nanosciences Holdings has obtained an oil and gas lease in Texas, marking a significant operational expansion for the company.
Value Line Inc. Holds Annual Shareholder Meeting Results
Value Line Inc. announces results from its annual shareholder meeting, including director elections and executive compensation votes.
Spruce Power to Redomicile from Delaware to Texas
Spruce Power Holding Corporation plans to redomicile from Delaware to Texas, enhancing its corporate environment while maintaining operations and stock listing.
bioAffinity Technologies reports 100% sales increase in lung test
bioAffinity Technologies announces over 100% increase in sales of its CyPath® Lung test, indicating strong growth in clinical adoption.